| abstract |
The present invention provides a combined pharmaceutical composition for treating or preventing cardiovascular disorders such as hyperlipidemia, coronary heart disease, particularly atherosclerosis. (A) S- [2-([[1- (2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl] 2-methylpropanethioate or an active prodrug thereof, and (b) at least one Combination pharmaceutical compositions, packages and kits comprising two HMG-CoA reductase inhibitors, and methods of treatment and prevention. [Selection figure] None |